Monopar Therapeutics Inc. (MNPR)
Nasdaq • MNPR • US61023L2079
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 27% of free float sold short, 8.5 days to cover, cost to borrow 1.21%. Sign up for live short interest data.
Market Cap
482m USD | # 6056 in US
Volume
158.88k shares | 14.49m USD
Shares Outstanding
6.71m
Free Float Shares
66.56% | 4.47m
